Caris Life Sciences (CAI) Treasury Shares (2024 - 2026)

Caris Life Sciences' Treasury Shares history runs 3 years deep, the most recent figure standing at $16.9 million for Q1 2026.

• In Q1 2026, Treasury Shares changed N/A year-over-year to $16.9 million; the TTM figure through Mar 2026 stood at $16.9 million (changed N/A YoY), while the FY2025 annual figure was $16.9 million, up 5020.0% from the prior year.
• Treasury Shares was $16.9 million for Q1 2026 at Caris Life Sciences, roughly flat from $16.9 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $9.3 million in Q1 2026 to a low of $182500.0 in Q2 2024.
• Historically, Treasury Shares has averaged $2.4 million across 3 years, with a median of $1.6 million in 2025.
• Biggest YoY gain for Treasury Shares was 5020.0% in 2025; the steepest drop was 5020.0% in 2025.
• A 3-year view of Treasury Shares shows it stood at $330000.0 in 2024, then surged by 5020.0% to $16.9 million in 2025, then changed by 0.0% to $16.9 million in 2026.
• The last three Treasury Shares figures came in at $16.9 million (Q1 2026), $16.9 million (Q4 2025), and $16.9 million (Q3 2025), per Business Quant data.